Core-binding factor β (CBFβ), but not CBFβ-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFβ-deficient embryonic stem cells

Blood

Volumn 97, Issue 8, 2001, Pages 2248-2256

  Miller, J D ^a   Stacy, T ^a   Liu, P P ^a   Speck, N A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; DNA BINDING PROTEIN; HYBRID PROTEIN; MYOSIN HEAVY CHAIN;

ACUTE LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ERYTHROID CELL; GENE DISRUPTION; GENE EXPRESSION; HEMATOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE; STEM CELL; TRANSGENE;

EID: 0035871809     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.8.2248     Document Type: Article

References (65)

1. PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 gene
2. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α
3. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
4. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
5. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain
6. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia
7. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization
8. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1
9. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
10. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
11. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo
12. Absence of fetal liver hematopoiesis in transcriptional co-activator, core binding factor β (Cbfb) deficient mice
13. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor
14. Interactions between the pair-rule genes runt, hairy, even-skipped and fushi tarazu and the establishment of periodic pattern in the Drosophila embryo
15. The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal
16. Expression and function of the Drosophila gene runt in early stages of neural development
17. Sex determination and dosage compensation in Drosophila melanogaster: Production of mate clones in XX females
18. Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1
19. 3, a Drosophila mutant lacking basiconic antennal sensilla
20. Genetics of a Drosophila phenoloxidase
21. Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
22. Cbfa 1, a candidate gene for Cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
23. Para-aortic splanchnopleura from early mouse embryos contain B1 a cell progenitors
24. Emergence of multipotent hematopoietic cells in the yolk sac and paraaortic splanchnopleura of 8.5 dpc mouse embryos
25. Diffuse intraembryonic hematopoiesis in normal and chimeric avian development
26. Development of hematopoietic stem cell activity in the mouse embryo
27. An early pre-liver intra-embryonic source of CFU-S in the developing mouse
28. Definitive hematopoiesis is autonomously initiated by the AGM region
29. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac
30. Ontogeny of the haemopoietic system: Yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo
31. B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac
32. Ontogeny of T cells: Development of pre-T cells from fetal liver and yolk sac in the thymus microenvironment
33. Hematopoietic stem cells in murine embryonic yolk sac and peripheral blood
34. Normal and neoplastic maturation of T-lineage lymphocytes
35. Definitive hematopoietic stem cells first emerge from the major arterial regions of the mouse embryo
36. Molecular basis of leukemogenesis
37. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
38. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
39. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1
40. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
41. Defects of embryonic hematopoiesis and lethal hemorrhaging in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11
42. The PEBP2βMYH11 fusion created by Inv(16)(p13; q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia
43. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor α (CBFα) subunit by the leukemia-related PEBP2/CBFβ-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation
44. The leukemic protein CBFβ-SMMHC sequesters CBFα2 into cytoskeletal filaments and aggregates
45. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor
46. In vitro differentiation of murine embryonic stem cells. New approaches to old problems
47. - embryonic stem cells
48. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line
49. The T-cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages
50. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding
51. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation
52. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain
53. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy
54. Versatile retroviral vectors for potential use in gene therapy
55. Generation of helper free retroviruses by transient transfection
56. Hematopoietic commitment during embryonic stem cell differentiation in culture
57. Functional dissection of the α and β subunits of the transcription factor PEBP2 and the redox susceptibility of its DNA binding activity
58. Overexpression, purification, and biophysical characterization of the heterodimerization domain of the core-binding factor β subunit
59. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors
60. Solution structure of core binding factor β and map of the CBFα binding site
61. Molecular insights into PEBP2/CBFβ-SMMHC associated acute leukemia revealed from the three-dimensional structure of PEBP2/CBFβ
62. Chromosome 16 inversion-generated fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukemia
63. Embryonic lethality and impairment of hematopoiesis in mice heterozygous for an AML1-ETO fusion gene
64. Cbfa2 is required for the formation of intraaortic hematopoietic clusters
65. Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias